Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Bosutinib receives positive CHMP opinion for conditional marketing authorization

Jan. 21, 2013

Phase I study of KPT-330 opens to patients with AML

Jan. 18, 2013

ArQule patents new protein kinase inhibitors for cancer

Jan. 18, 2013

French researchers disclose new monoclonal antibodies for cancer and other disorders

Jan. 18, 2013

New antineoplastic agents synthesized at Pharminox

Jan. 18, 2013

Serum albumin binding proteins developed at Ablynx

Jan. 18, 2013

AT-13148 begins U.K. phase I study for cancer

Jan. 17, 2013

Health Canada approves Afinitor for advanced breast cancer

Jan. 17, 2013

FDA grants priority review for afatinib in NSCLC with an EGFR mutation

Jan. 17, 2013

Novartis patent reveals p53/Mdm2 interaction inhibitors

Jan. 17, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...